Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
The use of immune checkpoint inhibitors (ICI) in cancer patients with solid organ allografts is hampered due to potential organ rejection. Here, the authors present a case report of a patient with kidney allograft and show that treatment with the mTOR inhibitor sirolimus preserves peripheral toleran...
Enregistré dans:
Auteurs principaux: | Khashayar Esfahani, Tho-Alfakar Al-Aubodah, Pamela Thebault, Réjean Lapointe, Marie Hudson, Nathalie A. Johnson, Dana Baran, Najwa Bhulaiga, Tomoko Takano, Jean-François Cailhier, Ciriaco A. Piccirillo, Wilson H. Miller |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7b6d74e8eca445f991f3a9a988480cef |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
par: Yi Zhang, et autres
Publié: (2021) -
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
par: Yoon MS
Publié: (2020) -
The mTOR pathway is necessary for survival of mice with short telomeres
par: Iole Ferrara-Romeo, et autres
Publié: (2020) -
mTOR-dependent phosphorylation controls TFEB nuclear export
par: Gennaro Napolitano, et autres
Publié: (2018) -
Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
par: Andrew Wang, et autres
Publié: (2017)